文献速递胃肠外科围术期管理与 ERAS

食管旁疝修补术可解决大多数患者不明原因缺铁性贫血:倾向匹配多中心研究

Surgical repair of paraesophageal hernia resolves unexplained iron deficiency anemia in the vast majority of patients: a propensity-matched multicenter study.
PubMed 文献 · Surg Endosc · 2026-05-21

该多中心回顾性研究分析1700例食管旁疝修补术患者,排除可识别出血源后纳入522例,其中136例不明原因缺铁性贫血与386例对照进行1:3倾向匹配。匹配后99例贫血患者与297例对照,12个月贫血缓解率93.4%,88.9%在3个月内血红蛋白正常,平均血红蛋白升高3.2 g/dL,82.8%成功停用铁剂。

要点

  • 食管旁疝修补术后12个月不明原因缺铁性贫血缓解率达93.4%。
  • 88.9%的患者在术后3个月内血红蛋白恢复正常。
  • 糖尿病和慢性肾脏病与贫血持续相关。

核心结论

  • 食管旁疝修补术后超过90%的不明原因缺铁性贫血患者贫血缓解,且即使解剖复发,疗效仍可能维持。
  • 建议对不明原因、难治性缺铁性贫血的食管旁疝患者考虑手术修补。

研究设计与样本

  • 多中心回顾性研究(2010-2024),分析1700例接受食管旁疝修补术的患者。
  • 排除可识别出血源后,522例纳入分析:136例不明原因缺铁性贫血与386例对照;倾向评分匹配(1:3)后99例贫血患者与297例对照。

主要发现

  • 基线血红蛋白贫血组10.5 ± 1.4 g/dL vs 对照组13.9 ± 1.2 g/dL(p < 0.001)。
  • 贫血严重程度:轻度62.6%,中度31.3%,重度6.1%;42.4%的患者就诊时完全无症状。
  • 78.2%的患者既往铁剂治疗失败,平均疗程5.8 ± 3.2个月。
  • 12个月贫血缓解率93.4%(92/99),88.9%在3个月内血红蛋白正常;平均血红蛋白升高3.2 g/dL(95% CI 2.9-3.5,p < 0.001)。
  • 铁蛋白从19.3 ± 11.8 ng/mL正常化至95.3 ± 38.5 ng/mL;82.8%的患者成功停用铁剂。

关键数值与推荐

  • 贫血缓解定义为12个月时血红蛋白女性> 12 g/dL、男性> 13 g/dL且未补铁。
  • 糖尿病(71.4% vs 28.3%)和慢性肾脏病(28.6% vs 3.3%)与贫血持续相关。

临床怎么用

  • 对不明原因、难治性缺铁性贫血的食管旁疝患者,应考虑手术修补作为治疗选择。
  • 术后应监测血红蛋白和铁蛋白,多数患者可在3个月内血红蛋白正常并停用铁剂。

局限性

  • 回顾性研究设计。
  • 仅7例贫血未缓解事件,未进行多因素分析。
  • 需要前瞻性研究建立循证标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Paraesophageal hernias (PEH) frequently associate with iron deficiency anemia (IDA) through unclear mechanisms. We investigated whether surgical repair effectively treats unexplained IDA in patients with PEH. METHODS: This multicenter retrospective study (2010-2024) analyzed 1700 patients undergoing hiatal hernia repair across Asuta Medical Centers. After excluding patients with identifiable bleeding sources (Cameron lesions, erosive gastritis, ulcers), 522 patients remained: 136 with unexplained IDA and 386 controls. Propensity score matching (1:3) aligned 99 anemic patients with 297 controls based on age, sex, BMI, and comorbidities. Primary endpoint was anemia resolution at 12 months (hemoglobin > 12 g/dL females, > 13 g/dL males without iron supplementation). RESULTS: Baseline hemoglobin was 10.5 ± 1.4 vs 13.9 ± 1.2 g/dL (p < 0.001). Anemia severity was mild (62.6%), moderate (31.3%), or severe (6.1%). Despite profound anemia, 42.4% were completely asymptomatic at presentation. Prior iron therapy had failed in 78.2% over 5.8 ± 3.2 months. Anemia resolution occurred in 93.4% (92/99) at 12 months, with 88.9% achieving normal hemoglobin by 3 months. Mean hemoglobin increased by 3.2 g/dL (95% CI 2.9-3.5, p < 0.001), with ferritin normalizing from 19.3 ± 11.8 to 95.3 ± 38.5 ng/mL. Iron supplementation was successfully discontinued in 82.8% of patients. Among 16 patients with hernia recurrence, 75% maintained normal hemoglobin despite anatomical failure. Control group hemoglobin remained unchanged (13.9 ± 1.2 to 13.9 ± 1.1 g/dL, p = 0.892). Due to only 7 non-resolution events, multivariate analysis was not performed; however, diabetes (71.4% vs. 28.3%) and chronic kidney disease (28.6% vs. 3.3%) were associated with persistent anemia. CONCLUSIONS: Unexplained IDA resolves in > 90% of patients following PEH repair, with durable results often maintained despite anatomical recurrence. These findings suggest PEH repair should be considered for patients with unexplained, refractory IDA. Prospective studies are needed to establish evidence-based criteria for this underrecognized indication.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kanani F, Shaiban M, Shwaartz C, et al. Surgical repair of paraesophageal hernia resolves unexplained iron deficiency anemia in the vast majority of patients: a propensity-matched multicenter study. Surg Endosc. 2026. PMID: 42168607. doi:10.1007/s00464-026-12900-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。